IMBRUVICA cpr pell 140 mg 28 pce
7680671090055
CH-67109
L01EL01
07.16.1.
Reimbursement limitations:
IMBRUV.Ein
Ibrutinib n’est pas remboursé chez les patients ayant progressé sous des inhibiteurs de la BTK.
…
1 / 3
google
Details
- Product number
- 6710901
- CPT
- -
- Packaging group
- 28
- Unit
- Tablette(n)
- Composition
- ibrutinibum 140 mg, lactosum monohydricum 28 mg, carmellosum natricum conexum, natrii laurilsulfas, povidonum K 25, cellulosum microcristallinum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum, talcum, E 171, E 172, pro compresso obducto corresp. natrium 1.14 mg.
Articles (1)
Imbruvica 140 mg, Filmtabletten
Filmtabletten
28
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
140.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
28.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
1.14 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 1509.10
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/12/2019
Authorization holder
Janssen-Cilag AG
6300 Zug
Authorization information
- Swissmedic authorization number
- 67109
- Drug name
- Imbruvica, Filmtabletten
- Galenic form
- FILM
- ATC Code
- L01EL01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 18/04/2019
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- IMBRUVICA cpr pell 140 mg 28 pce
- Description (DE)
- IMBRUVICA Filmtabl 140 mg 28 Stk
- Market launch
- 18/04/2019
- Narcotic (BTM)
- No